[CIS PIDD] [cis-pidd] PFAPA and low memory B cells

CIS-PIDD cis-pidd at lists.clinimmsoc.org
Sat Jul 16 10:00:12 EDT 2016


i agree with prednisona 1 mg/kg on the first day, single dose, on demand (
its abortive). if it requires corticosteroids often, try tonsilectomy.
colchicine its not an option. In adults there are some reports of
refractory pfapa treated with canaquinumab 150 mg SC 6/6 weeks.

2016-07-15 20:50 GMT-03:00 CIS-PIDD <cis-pidd at lists.clinimmsoc.org>:

> Have you tried prednisone?  1-2 days at the start of fever should stop it.
> I also agree with tonsillectomy since she has had this for some time
>
> Sent from my iPhone
>
> On Jul 15, 2016, at 4:40 PM, CIS-PIDD <cis-pidd at lists.clinimmsoc.org
> <mailto:cis-pidd at lists.clinimmsoc.org>> wrote:
>
> Dear Richard,
> from the pediatric perspective prior reported cure rates after
> adenotonsillectomy are even lower than experienced in clinical practice.
> PFAPA children usually have tonsil enlargement only within episodes. With
> long-lasting recurrent PFAPA episodes I would favour surgery in your
> patient.
> BTW I wonder if long-term antibody response will be maintained. However it
> seems to work fine in terms of antibody titers (despite low SmB cells)
> All the best,
> Nacho
>
> Luis I. Gonzalez-Granado. MD.
> Immunodeficiencies Unit.
> Hospital 12 de octubre.
> Research Institute Hospital 12 octubre (i+12)
> Av. Cordoba S/N. 28041. Madrid. Spain
> Tel. 0034606732959 /  0034913908569  /  Fax
> 0034913908772<tel:0034934893039>
> luisignacio.gonzalez at salud.madrid.org<mailto:
> luisignacio.hdoc at salud.madrid.org>
> ORCID ID:  orcid.org/0000-0001-6917-8980<
> http://orcid.org/0000-0001-6917-8980>
> Researcher ID: B-9257-2009
> ResearchGate:https://www.researchgate.net/profile/Luis_Gonzalez-Granado
> LinkedIn:  https://es.linkedin.com/in/nachgonzalez
>
> 2016-07-15 21:56 GMT+02:00 CIS-PIDD <cis-pidd at lists.clinimmsoc.org<mailto:
> cis-pidd at lists.clinimmsoc.org>>:
> Colleagues,
>
> I am seeing a 19 yo woman who has long carried the diagnosis of Selective
> IgA Deficiency. She has had multiple episodes of sinusitis and one
> pneumonia. For the past year, she has had textbook presentations of PFAPA
> with all four characteristics every 3-4 weeks. She recently had a
> thyroidectomy for thyroid cancer.
>
> Her laboratory studies are below. At this time she is being treated with
> prophylactic TMP/SMX. My questions are: What would you do for the PFAPA
> which is debilitating because of the 5-7 day duration of the episodes and
> their frequency (tonsils are visible but small). What additional laboratory
> studies may be of help?
>
> Thanks,
> Richard Wasserman
> Dallas
>
>  Immunoglobulin A, Qn, Serum
>
>                        [L]  9 mg/dL                     87-352
>
>
>  Immunoglobulin G, Qn, Serum
>
>                             1291 mg/dL                  549-1584
>
>  Immunoglobulin M, Qn, Serum
>
>                             110 mg/dL                   58-230
>
> Immunoglobulin E, Total
>
>                             24 IU/mL                    0-100
>
>
>
>
> Post Vaccination Titers
>
>
> Pneumococcal Ab (23 Serotype) (812166)
>
>   Pneumo Ab Type 1*         11.4 ug/mL                  >1.3
>
>   Pneumo Ab Type 3*         9.8 ug/mL                   >1.3
>
>   Pneumo Ab Type 4*         >15.8 ug/mL                 >1.3
>
>   Pneumo Ab Type 8*         7.6 ug/mL                   >1.3
>
>  Pneumo Ab Type 9 (9N)*
>
>                             13.8 ug/mL                  >1.3
>
>  Pneumo Ab Type 12 (12F)*
>
>                             11.9 ug/mL                  >1.3
>
>   Pneumo Ab Type 14*        >31.0 ug/mL                 >1.3
>
> ! Pneumo Ab Type 17 (17F)*
>
>                             16.4 ug/mL                  >1.3
>
>  Pneumo Ab Type 19 (19F)*
>
>                             23.6 ug/mL                  >1.3
>
> ! Pneumo Ab Type 2*         4.8 ug/mL                   >1.3
>
> ! Pneumo Ab Type 20*        4.3 ug/mL                   >1.3
>
> ! Pneumo Ab Type 22 (22F)*
>
>                             53.9 ug/mL                  >1.3
>
>  Pneumo Ab Type 23 (23F)*
>
>                             2.0 ug/mL                   >1.3
>
>  Pneumo Ab Type 26 (6B)*
>
>                             51.7 ug/mL                  >1.3
>
>  Pneumo Ab Type 34 (10A)*
>
>                             >32.9 ug/mL                 >1.3
>
>  Pneumo Ab Type 43 (11A)*
>
>                             12.8 ug/mL                  >1.3
>
>  Pneumo Ab Type 5*         6.5 ug/mL                   >1.3
>
>  Pneumo Ab Type 51 (7F)*
>
>                             5.8 ug/mL                   >1.3
>
>  Pneumo Ab Type 54 (15B)*
>
>                             >29.3 ug/mL                 >1.3
>
>  Pneumo Ab Type 56 (18C)*
>
>                             5.2 ug/mL                   >1.3
>
>  Pneumo Ab Type 57 (19A)*
>
>                             24.8 ug/mL                  >1.3
>
>  Pneumo Ab Type 68 (9V)*
>
>                             18.8 ug/mL                  >1.3
>
>  Pneumo Ab Type 70 (33F)*
>
>                             12.2 ug/mL                  >1.3
>
>
> Haemophilus influenzae B IgG (138271)
>
>  Haemophilus influenzae B IgG
>
>                             >9.00 ug/mL
>
>
> Tetanus Antitoxoid IgG Ab (163691)
>
>  Tetanus Antitoxoid IgG Ab
>
>                             >7.00 IU/mL                 <0.10
>
>
> Diphtheria Antitoxoid Ab (163709)
>
>  Diphtheria Antitoxoid Ab
>
>                             1.09 IU/mL                  <0.10
>
>
>
> T- and B-Lymphocyte/Nat Killer (505370)
>
>   Abs.CD19+ Lymphs          84 /uL                      12-645
>
>   % CD19+ Lymphs       [L]  2.8 %                       3.3-25.4
>
>   Absolute CD 3        [H]  2553 /uL                    622-2402
>
>   % CD 3 Pos. Lymph.        85.1 %                      57.5-86.2
>
>   Absolute CD 4 Helper      834 /uL                     359-1519
>
>   % CD 4 Pos. Lymph.   [L]  27.8 %                      30.8-58.5
>
>   Abs. CD 8 Suppressor [H]  1470 /uL                    109-897
>
>   % CD 8 Pos. Lymph.   [H]  49.0 %                      12.0-35.5
>
>   CD4/CD8 Ratio        [L]  0.57                        0.92-3.72
>
>   Ab NK (CD56/16)           327 /uL                     24-406
>
>   % NK (CD56/16)            10.9 %                      1.4-19.4
>
>
> B-Cell Memory and Naive Panel (818314)
>
> ! B-cells % CD19       [L]  3 %                         5-26
>
> ! B-cells Absolute CD19
>
>                             82 cells/uL                 58-558
>
> ! Naive B-cell %CD19+/CD27-/IgD+
>
>                             60 %                        29-93
>
> ! Naive BCL Abs CD19+/CD27-/IgD+
>
>                             49 cells/uL                 22-423
>
> ! Non-switched Memory %
>
>                             7 %                         2-25
>
> ! Non-switch Abs            5 cells/uL                  4-66
>
> ! Class-switched Memory %
>
>                        [L]  <1 %                        3-23
>
> ! Class-switched Abs   [L]  1 cells/uL                  4-62
>
> ! IgM Only Memory %    [H]  15.6 %                      .3-6.0
>
> ! IgM Only Memory Abs       12.8 cells/uL               .6-16.4
>
> ! Total Memory B-cell%CD19/CD27+
>
>                             23 %                        7-48
>
> ! Tot Mem BCL Absol CD19+/CD27+
>
>                             19 cells/uL                 13-148
>
>
>
> ANA w/Reflex (164902)
>
>   ANA Direct           [A]  Positive                    Negative
>
>
> Tests: (9) ENA+DNA/DS+Centro+Scl 70+Sj... (160033)
>
>   Anti-DNA (DS) Ab Qn       2 IU/mL                     0-9
>
>                                        Negative      <5
>
>                                        Equivocal  5 - 9
>
>                                        Positive      >9
>
>
>
>   RNP Antibodies            0.2 AI                      0.0-0.9
>
>   Smith Antibodies          <0.2 AI                     0.0-0.9
>
>  Antiscleroderma-70 Antibodies
>
>                        [H]  1.2 AI                      0.0-0.9
>
>   Sjogren's Anti-SS-A       <0.2 AI                     0.0-0.9
>
>   Sjogren's Anti-SS-B       <0.2 AI                     0.0-0.9
>
>  Anti-Centromere B Antibodies
>
>                             <0.2 AI                     0.0-0.9
>
>  ANCA Panel (163873)
>
>
>  Antimyeloperoxidase (MPO) Abs
>
>                             <9.0 U/mL                   0.0-9.0
>
>  Antiproteinase 3 (PR-3) Abs
>
>                             <3.5 U/mL                   0.0-3.5
>
>   Cytoplasmic (C-ANCA)      <1:20 titer                 Neg:<1:20
>
>   Perinuclear (P-ANCA)      <1:20 titer                 Neg:<1:20
>
>   Atypical pANCA            <1:20 titer                 Neg:<1:20
>
> --
> Richard L. Wasserman, MD, PhD
> Allergy Partners of North Texas
> 7777 Forest Lane, Suite B-332
> Dallas, Texas 75230
> Office (972) 566-7788
> Fax (972) 566-8837
> Cell (214) 697-7211
>
> ---
>
> You are currently subscribed to cis-pidd as: nachgonzalez at gmail.com
> <mailto:nachgonzalez at gmail.com>.
>
> To unsubscribe click here:
> http://cts.dundee.net/u?id=96396812.66aedac07f1044b5f6e7c94e3e51e2ac&n=T&l=cis-pidd&o=3745594
>
> (It may be necessary to cut and paste the above URL if the line is broken)
>
> or send a blank email to
> leave-3745594-96396812.66aedac07f1044b5f6e7c94e3e51e2ac at lyris.dundee.net
> <mailto:
> leave-3745594-96396812.66aedac07f1044b5f6e7c94e3e51e2ac at lyris.dundee.net>
>
>
> ---
>
> You are currently subscribed to cis-pidd as: jverbsky at mcw.edu<mailto:
> jverbsky at mcw.edu>.
>
> To unsubscribe click here:
> http://cts.dundee.net/u?id=96396710.777d26b6da96d84a8b0d5e2d208337f2&n=T&l=cis-pidd&o=3745654
>
> (It may be necessary to cut and paste the above URL if the line is broken)
>
> or send a blank email to
> leave-3745654-96396710.777d26b6da96d84a8b0d5e2d208337f2 at lyris.dundee.net
> <mailto:
> leave-3745654-96396710.777d26b6da96d84a8b0d5e2d208337f2 at lyris.dundee.net>
>
> ---
> You are currently subscribed to cis-pidd as:
> leonardo.mendonca at hc.fm.usp.br.
> To unsubscribe click here:
> http://cts.dundee.net/u?id=96396764.5d5926a8e01f475d7bf6717a52d027f0&n=T&l=cis-pidd&o=3746023
> or send a blank email to
> leave-3746023-96396764.5d5926a8e01f475d7bf6717a52d027f0 at lyris.dundee.net
>



-- 
*Dr Leonardo Oliveira Mendonça*
Médico do Serviço de Imunologia Clínica e Alergia Hospital Das Clinicas,
Faculdade de Medicina da Universidade de São Paulo
Unidade Convênios e Particulares/ Ambulatório de Doenças Autoinflamatórias

*Leonardo Oliveira Mendonça,MD*
Departament of Clinical Immunology and Allergy  at Hospital das Clínicas,
School of Medicine - University of São Paulo
Private Healthcare Unit/ Autoinflammatory Disease Unit

email: *leonardo.mendonca at hc.fm.usp.br <leonardo.mendonca at hc.fm.usp.br>*
telefones/phone number: +55-11-26619571/ +55-11-26617825/ FAX: 011-2661 8173

---
You are currently subscribed to cis-pidd as: pagid at list.clinimmsoc.org.
To unsubscribe click here: http://cts.dundee.net/u?id=96396833.5a9591ccd1e327fe6bc4d1543298c482&n=T&l=cis-pidd&o=3746740
or send a blank email to leave-3746740-96396833.5a9591ccd1e327fe6bc4d1543298c482 at lyris.dundee.net
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://pairlist7.pair.net/pipermail/pagid/attachments/20160716/79238882/attachment-0001.html>


More information about the PAGID mailing list